Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of GSK962040 in diabetic gastroparesis
2010-023186-21Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic gastroparesis comparing GSK962040 once daily with Placebo once daily (2 arms). Primary endpoint: Gastric emptying by 13C oral breath test. Started Dec 2010; status: completed.
02
Drugs
camicinal
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on 2010-023186-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023186-21.